Navigation Links
New agent strikes at respiratory syncytial virus replication
Date:5/5/2008

GALVESTON, Texas University of Texas Medical Branch at Galveston researchers have achieved promising results with a potential new weapon against respiratory syncytial virus, the most common cause of infant hospitalization in the United States.

In an effort to find an effective antiviral therapy for RSV, the scientists tested two types of complex, custom-designed molecule to interfere with the genetic machinery that RSV uses to replicate, or copy itself, within cells. Both of the so-called morpholino oligomers, created by Oregon-based AVI BioPharma, penetrated cultured human airway cells easily and produced only minimal toxicity. One of the two, designated AUG-2, significantly reduced RSV replication in both cell culture and mouse experiments.

Viral replication is one of the major pathogenetic processes of RSV, and we badly need a specific antiviral therapy, said UTMB Dr. Roberto Garofalo, senior author of a paper on the study to be published in the June issue of Molecular Therapy and now available in the Advance Online Publication section of the journals website. That's what an agent like this morpholino could give us.

RSV infects almost all children by age two, but normally causes only a cold-like upper respiratory infection. In some babies, however, it spreads to the lungs, where the inflammation it generates causes coughing, wheezing and extreme difficulty in breathing, a life-threatening clinical syndrome known as bronchiolitis.

Recent research by Garofalo and other investigators suggests that two key factors drive RSV bronchiolitis: an inflammatory overreaction by the cells that line the airways of the lungs, and a failure to respond to RSV by T lymphocytes (also known as T cells), immune system cells that ordinarily act to control viral infections.

Because a dangerous inflammatory response occurs so soon after RSV begins replicating in the lungs, Garofalo said, antiviral therapy by itself is unlikely to be suf
'/>"/>

Contact: Jim Kelly
jpkelly@utmb.edu
409-772-8791
University of Texas Medical Branch at Galveston
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Medical Futures signs North American licensing rights to New Biologic agent for Ulcerative Colitis
2. China Medical Technologies Completed the Development of Prostate Cancer FISH Reagent
3. New research shows benefits of ultrasound contrast agents outweigh potential risk to heart patients
4. Peter Burg Appointed as Co-Chair of the Plaintiffs Steering Committee and the Executive Committee for the Gadolinium-Based Contrast Agents Product Liability Multi-District Litigation
5. FluoroPharma Inc. Expands Technology Platform to Include Agents for Alzheimers Disease (AD)
6. NSAIDs: Painkillers, inflammation inhibitors, anti-cancer drugs and new de-methylating agents
7. China Medical Technologies Receives CE Mark for Two ECLIA Analyzers and 15 Reagents
8. Sagent Pharmaceuticals Launches Ciprofloxacin Injection, USP, 5% Dextrose Premix Bag
9. IUPUI scientists report first 3-D view of anti-cancer agent
10. Cardinal Health, GE Healthcare Broaden Relationship to Offer Greater Access to Myoview(TM) Imaging Agent
11. Parker Waichman Alonso LLP Files Suit Against General Electric Company on Behalf of a Man Who Developed Nephrogenic Systemic Fibrosis (NSF) from Contrast Agent Omniscan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... September 17, 2014 The global metrology ... worth due to the key driving factors of increasing ... expected CAGR of 8.2 % puts the metrology services ... in 2018, as stated in a Transparency Market Research ... Size, Share, Growth, Trends, and Forecast 2012 – 2018”. ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 For over ... supplier of MadgeTech data logging products to industries in ... equipment and the development of management systems for certification ... service, quality, and technical support. , MadgeTech Inc. ... reach internationally. “We are very pleased to see the ...
(Date:9/17/2014)... NY (PRWEB) September 17, 2014 ... and Access Management (IdM/IAM) solutions and Boston ... announced their business partner relationship. Under ... Systems’ technology to automate functionality within its ... Boston Software Systems provides healthcare automation platforms ...
(Date:9/17/2014)... NJ (PRWEB) September 17, 2014 ... Application Security Testing (SAST) tool, at AppSec USA 2014 ... from 9 am to 6 pm at booth G4 ... one of the leading software security conferences for developers, ... a tool that provides developers and managers with the ...
(Date:9/17/2014)... release is available in Spanish . ... more than half of the population in our Community. ... of which affects liver function. Fat accumulates in the ... inflammation, fibrosis and finally, cirrhosis. To date, the most ... biopsy. Imaging techniques such as abdominal ecography detect it ...
Breaking Medicine News(10 mins):Health News:Metrology Services Market to Hit USD 720.3 Million by 2018: Transparency Market Research 2Health News:Metrology Services Market to Hit USD 720.3 Million by 2018: Transparency Market Research 3Health News:Main Solutions Now Distributing MadgeTech Data Loggers in Bulgaria 2Health News:Tools4ever Partners with Boston Software Systems to Automate Identity and Password Management 2Health News:Tools4ever Partners with Boston Software Systems to Automate Identity and Password Management 3Health News:Tools4ever Partners with Boston Software Systems to Automate Identity and Password Management 4Health News:Fasoo to Introduce Their Testing Tool to Improve Software Security and Quality at AppSec USA 2014 2Health News:Magnetic resonance helps to detect and quantify fat in liver 2
... An international team of researchers says abortion stigma is ... women who,ve had abortions. As a result, they,re launching ... stigma surrounding abortion. Their invited paper, "Abortion ... published in the current journal, Women,s Health Issues ...
... people every day, are a surprisingly common cause of ... hospital after sustaining stepladder injuries, many of which resulted ... how improved design and user behavior can decrease the ... HFES 55th Annual Meeting presentation, "The Role of Human ...
... (HealthDay News) -- Many members of low-income families are not ... In assessing the families, eating patterns and the nutritional ... 70 percent of the 100 families, who were newly enrolled ... amounts of several vital nutrients, including vitamins A and C, ...
... sorafenib responded to the flu vaccine, which suggests the ... as previously feared, according to a study in ... Association for Cancer Research. Keith Flaherty, M.D., ... and a senior editor of Clinical Cancer Research, said ...
... of scheduling chemotherapy treatments has been substantially reduced by a ... from the Sauder School of Business at the University of ... Called Chemo SmartBook, the innovative new scheduling system ... from the Health Employers Association of British Columbia in the ...
... many, a tax on soda is a no-brainer in advancing the ... in recent years that conclude that sugary drinks have a lot ... obese people tend to drink diet sodas, and therefore taxing soft ... weapon in combating obesity, according to a new Northwestern University study. ...
Cached Medicine News:Health News:International team explores the stigma surrounding abortion 2Health News:Improved stepladder design may decrease injuries 2Health News:Low-Income Families Often Miss Out on Proper Nutrition 2Health News:Patients treated with sunitinib and sorafenib respond to flu vaccine 2Health News:Innovative UBC-BC Cancer Agency system reduces waitlisting for chemotherapy patients 2Health News:Innovative UBC-BC Cancer Agency system reduces waitlisting for chemotherapy patients 3Health News:Can soda tax curb obesity? 2
(Date:9/17/2014)... , Sept. 17, 2014   OTEMR, Inc. ... Edition Complete EHR certification, which designates that the software ... Stage 1 and Stage 2 Meaningful Use measures required ... Reinvestment Act (ARRA).  ONETOUCH EMR 2.0 was certified on ... Office of the National Coordinator-Authorized Certification Body (ONC-ACB) and ...
(Date:9/17/2014)... MUMBAI, India , September 17, 2014 ... TRPA1 antagonist, GRC 17536, has shown positive data in ... with painful diabetic neuropathy , ... Transient Receptor Potential Ankyrin 1 (TRPA1) antagonist, GRC 17536 ... blind, placebo controlled, multi-centre, proof of concept study conducted ...
(Date:9/17/2014)... 17, 2014  Bayer HealthCare will present data on ... th Annual Meeting, which takes place September 18-20 ... which will be shared through poster presentations, showcase Bayer,s ... Data will be presented in a scientific forum. ... in hemophilia A patients, Bayer is maintaining its commitment ...
Breaking Medicine Technology:OTEMR, Inc.'s ONETOUCH EMR Achieves ONC HIT 2014 Edition COMPLETE EHR Certification from ICSA Labs 2OTEMR, Inc.'s ONETOUCH EMR Achieves ONC HIT 2014 Edition COMPLETE EHR Certification from ICSA Labs 3Glenmark's TRPA1 Antagonist 'GRC 17536' Shows Positive Data in a Proof of Concept Study 2Glenmark's TRPA1 Antagonist 'GRC 17536' Shows Positive Data in a Proof of Concept Study 3Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C. 2Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C. 3Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C. 4
... and SAN FRANCISCO , May 31 Dendreon Corporation ... the integrated analysis of four randomized PROVENGE® (sipuleucel-T) clinical trials of an ... of the American Urological Association (AUA) in San Francisco . ... "The approval of PROVENGE ...
... , May 28, 2010 Shire plc (LSE: SHP,NASDAQ: ... Paragraph IV Notice Letter today from Zydus,Pharmaceuticals USA, Inc. ("Zydus") advising of ... of Shire,s 1.2g,mesalamine delayed release tablets, LIALDA(R). , ... LIALDA is protected by the ...
Cached Medicine Technology:Dendreon Announces Presentation of PROVENGE Data at the American Urological Association Annual Meeting 2Dendreon Announces Presentation of PROVENGE Data at the American Urological Association Annual Meeting 3Dendreon Announces Presentation of PROVENGE Data at the American Urological Association Annual Meeting 4Shire Receives LIALDA(R) Paragraph IV Notice Letter From Zydus Pharmaceuticals 2Shire Receives LIALDA(R) Paragraph IV Notice Letter From Zydus Pharmaceuticals 3
Agility has delivered a RFID-enabled mobile asset management program....
... VerdaSee Location-ID™ is a family of ... equipment and individuals inside hospitals, healthcare ... frequency technology. The target tracking areas ... a series of radio frequency identification ...
The WatchMate LC model is a cost-effective solution for monitoring a single exit, and provides local notification of an alarm....
Assetrac allows identification, location, and protection of your assets....
Medicine Products: